PSYD_0302: BIRMINGHAM

This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials. A randomised, double-blind, placebo-controlled trial in participants with a recent-onset schizophrenia-spectrum disorder with continuing positive symptoms. Contributors and PIs: John F. W. Deakin Neuroscience and Psychiatry Unit, The University of Manchester, Manchester, UK Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK Key Details & Variables Data Type Image data/Feature data Age Range 19-34 Number of Participants 28 Diagnostic Criteria SCZ Number of Clinical Subjects 18 Number of Clinical Subjects (follow-up) 10 Number of Control Subjects N/A Number of Control Subjects (follow-up) N/A Demographic Information Age, Sex, Ethnicity, Handedness, Education Clinical Measures PANSS, CDSS, EPS, MAH, COO Cognitive Measures N/A Clinical Functioning Measures GAF Antipsychotic Medication Information Recorded Yes Antipsychotic Medication Name/ Antipsychotic Type Name Antipsychotic Dose Recorded Yes CPZ Equivalents Recorded N/A Other Medication Variables Recorded Yes Recreational Drug/ Alcohol Use Yes Note: the above table features key details and variables and is not an exhaustive list.